Melanoma Research Program Survivorship Research Award
This grant funds innovative research to improve the health and quality of life for melanoma survivors, requiring collaboration with survivors or their supporters, with up to $1.02M per award over 3 years.
Funder: Dept. of the Army -- USAMRAA
Due Dates: September 22, 2026 (Pre-Application/LOI) | October 14, 2026 (Full Application) | October 20, 2026 (End of Application Verification Period)
Funding Amounts: Total program funding: $2.04M; up to $1.02M total costs per award for up to 3 years; ~2 awards expected.
Summary: Supports innovative research to improve health and quality of life for melanoma survivors, their families, and care partners.
Key Information: Application must include at least one melanoma consumer collaborator; clinical trials are allowed.
Description
This opportunity, offered by the Dept. of the Army's U.S. Army Medical Research Acquisition Activity (USAMRAA) through the Congressionally Directed Medical Research Programs (CDMRP), aims to fund research that advances the field of melanoma survivorship. The focus is on projects that address quality of life, health, and overall well-being for melanoma survivors, their families, and care partners. The program encourages applications proposing evidence-based interventions, behavioral health science, survivor and care partner well-being, and psychosocial outcomes, with an emphasis on collaborative research that integrates the lived experience of those affected by melanoma.
Proposed studies must go beyond survival outcomes to include aspects such as quality of life, function, and health. Projects focusing solely on animal models or survival without these considerations are not responsive. Clinical trials are permitted under this award.
